InspireMD
NSPR
7 hedge funds and large institutions have $815K invested in InspireMD in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.
869% more capital invested
Capital invested by funds: $84.1K → $815K (+$731K)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
40% more funds holding
Funds holding: 5 → 7 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.37M |
| 2 |
VF
Virtu Financial
New York
|
+$281K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$41.4K |
| 4 |
Bank of New York Mellon
New York
|
+$24.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$24.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4K |
NSPR Hedge Fund Activity: Q4 2017 in Review
7 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2017, worth a combined $815K — up 869% from $84.1K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NSPR positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.37M. The largest seller was Goldman Sachs, exiting entirely with an estimated $6K sold.
- 7 institutional investors held InspireMD (NSPR) as of Q4 2017, up from 5 in Q3 2017.
- Funds reported $815K of InspireMD stock for Q4 2017, up 869% quarter-over-quarter.
- 3 funds opened new InspireMD positions in Q4 2017 and 1 closed out, a net change of +2 holders.
- The largest InspireMD buyer in Q4 2017 was Sabby Management, an estimated $1.37M added.
- The largest InspireMD seller in Q4 2017 was Goldman Sachs, an estimated $6K sold.
Based on aggregated 13F filings for Q4 2017.